Medibank Historical Balance Sheet

MPL Stock

3.83 0.02 0.52%

Trend analysis of Medibank Private balance sheet accounts such as Retained Earnings of 1.4 B provides information on Medibank Private's total assets, liabilities, and equity, which is the actual value of Medibank Private to its prevalent stockholders. By breaking down trends over time using Medibank Private balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Medibank Private latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medibank Private is a good buy for the upcoming year.

Medibank Private Inventory

(1.02 Billion)

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medibank Private. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Medibank Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Medibank Private at a specified time, usually calculated after every quarter, six months, or one year. Medibank Private Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Medibank Private and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Medibank currently owns. An asset can also be divided into two categories, current and non-current.

Medibank Private Balance Sheet Chart

At this time, Medibank Private's Non Current Liabilities Total is comparatively stable compared to the past year. Long Term Investments is likely to gain to about 334.5 M in 2024, whereas Other Liabilities is likely to drop slightly above 174.3 M in 2024.

Total Assets Total Stockholder Equity Other Liab Retained Earnings

Add Fundamental

Total Assets

Total assets refers to the total amount of Medibank Private assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Medibank Private books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Most accounts from Medibank Private's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Medibank Private current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medibank Private. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Total Stockholder Equity	1.9B	2.1B	2.3B	1.5B
Total Assets	4.6B	4.4B	4.7B	3.1B

Total Stockholder Equity Total Assets

Medibank Private balance sheet Correlations

	Total Assets	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Short Term Investments	Total Liab	Intangible Assets	Property Plant Equipment	Common Stock	Good Will	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Current Assets	Net Tangible Assets	Net Receivables
Total Assets		0.97	0.05	0.97	0.44	0.48	0.02	0.39	0.51	0.61	0.41	-0.07	0.69	0.14	0.6	0.14	0.57	0.01	-0.72	-0.24	-0.07	0.74	-0.63	0.54	0.76	-0.48
Total Stockholder Equity	0.97		0.01	1.0	0.42	0.47	-0.04	0.36	0.45	0.63	0.32	-0.11	0.71	0.14	0.47	0.12	0.55	0.04	-0.7	-0.21	-0.11	0.77	-0.55	0.48	0.78	-0.49
Other Liab	0.05	0.01		-0.02	0.15	0.52	-0.04	-0.11	-0.32	-0.2	0.25	-0.02	0.13	0.11	-0.3	0.1	-0.22	0.16	0.31	0.18	-0.02	-0.32	0.26	-0.17	-0.19	0.15
Retained Earnings	0.97	1.0	-0.02		0.43	0.45	0.01	0.41	0.45	0.66	0.3	-0.09	0.69	0.15	0.5	0.06	0.55	-0.01	-0.7	-0.24	-0.09	0.78	-0.56	0.48	0.78	-0.47
Accounts Payable	0.44	0.42	0.15	0.43		0.4	0.46	0.33	-0.32	0.61	0.72	0.28	-0.16	-0.33	0.01	-0.09	0.4	-0.42	-0.04	-0.56	0.28	0.16	0.13	-0.25	-0.05	0.19
Cash	0.48	0.47	0.52	0.45	0.4		-0.04	0.12	0.14	0.39	0.62	-0.06	0.51	-0.24	0.16	0.25	-0.25	0.12	-0.1	0.4	-0.06	0.14	-0.22	0.21	0.13	-0.2
Other Assets	0.02	-0.04	-0.04	0.01	0.46	-0.04		0.75	-0.4	0.46	0.17	0.89	-0.45	-0.07	0.16	-0.67	-0.05	-0.97	0.31	-0.48	0.89	-0.06	0.28	-0.55	-0.39	0.76
Short Term Investments	0.39	0.36	-0.11	0.41	0.33	0.12	0.75		0.04	0.65	0.04	0.6	-0.02	0.12	0.49	-0.64	0.08	-0.69	-0.09	-0.35	0.6	0.44	-0.15	-0.09	0.12	0.35
Total Liab	0.51	0.45	-0.32	0.45	-0.32	0.14	-0.4	0.04		0.24	0.04	-0.48	0.68	0.37	0.8	0.25	0.21	0.45	-0.75	0.23	-0.48	0.49	-0.93	0.93	0.67	-0.74
Intangible Assets	0.61	0.63	-0.2	0.66	0.61	0.39	0.46	0.65	0.24		0.49	0.25	0.13	-0.05	0.46	-0.35	0.27	-0.46	-0.32	-0.39	0.25	0.45	-0.28	0.09	0.17	0.02
Property Plant Equipment	0.41	0.32	0.25	0.3	0.72	0.62	0.17	0.04	0.04	0.49		0.08	0.03	-0.27	0.18	0.38	0.16	-0.09	-0.09	-0.12	0.08	-0.02	-0.16	0.07	-0.08	-0.04
Common Stock	-0.07	-0.11	-0.02	-0.09	0.28	-0.06	0.89	0.6	-0.48	0.25	0.08		-0.37	-0.09	-0.03	-0.44	-0.25	-0.9	0.5	-0.2	1.0	-0.23	0.42	-0.66	-0.44	0.84
Good Will	0.69	0.71	0.13	0.69	-0.16	0.51	-0.45	-0.02	0.68	0.13	0.03	-0.37		0.26	0.44	0.38	0.08	0.48	-0.58	0.42	-0.37	0.48	-0.66	0.71	0.75	-0.68
Other Current Liab	0.14	0.14	0.11	0.15	-0.33	-0.24	-0.07	0.12	0.37	-0.05	-0.27	-0.09	0.26		0.31	-0.14	0.17	0.14	-0.2	-0.09	-0.09	0.06	-0.35	0.34	0.32	-0.12
Total Current Liabilities	0.6	0.47	-0.3	0.5	0.01	0.16	0.16	0.49	0.8	0.46	0.18	-0.03	0.44	0.31		-0.1	0.3	-0.08	-0.71	-0.11	-0.03	0.58	-0.88	0.72	0.55	-0.42
Property Plant And Equipment Net	0.14	0.12	0.1	0.06	-0.09	0.25	-0.67	-0.64	0.25	-0.35	0.38	-0.44	0.38	-0.14	-0.1		0.04	0.67	-0.18	0.46	-0.44	-0.04	-0.24	0.38	0.26	-0.51
Net Debt	0.57	0.55	-0.22	0.55	0.4	-0.25	-0.05	0.08	0.21	0.27	0.16	-0.25	0.08	0.17	0.3	0.04		0.01	-0.7	-0.78	-0.25	0.61	-0.38	0.33	0.58	-0.43
Non Current Assets Total	0.01	0.04	0.16	-0.01	-0.42	0.12	-0.97	-0.69	0.45	-0.46	-0.09	-0.9	0.48	0.14	-0.08	0.67	0.01		-0.29	0.5	-0.9	0.02	-0.33	0.61	0.38	-0.75
Non Currrent Assets Other	-0.72	-0.7	0.31	-0.7	-0.04	-0.1	0.31	-0.09	-0.75	-0.32	-0.09	0.5	-0.58	-0.2	-0.71	-0.18	-0.7	-0.29		0.24	0.5	-0.85	0.87	-0.84	-0.88	0.83
Cash And Short Term Investments	-0.24	-0.21	0.18	-0.24	-0.56	0.4	-0.48	-0.35	0.23	-0.39	-0.12	-0.2	0.42	-0.09	-0.11	0.46	-0.78	0.5	0.24		-0.2	-0.29	-0.07	0.2	-0.06	-0.18
Common Stock Shares Outstanding	-0.07	-0.11	-0.02	-0.09	0.28	-0.06	0.89	0.6	-0.48	0.25	0.08	1.0	-0.37	-0.09	-0.03	-0.44	-0.25	-0.9	0.5	-0.2		-0.23	0.42	-0.66	-0.44	0.84
Other Current Assets	0.74	0.77	-0.32	0.78	0.16	0.14	-0.06	0.44	0.49	0.45	-0.02	-0.23	0.48	0.06	0.58	-0.04	0.61	0.02	-0.85	-0.29	-0.23		-0.65	0.57	0.84	-0.58
Other Stockholder Equity	-0.63	-0.55	0.26	-0.56	0.13	-0.22	0.28	-0.15	-0.93	-0.28	-0.16	0.42	-0.66	-0.35	-0.88	-0.24	-0.38	-0.33	0.87	-0.07	0.42	-0.65		-0.95	-0.76	0.77
Total Current Assets	0.54	0.48	-0.17	0.48	-0.25	0.21	-0.55	-0.09	0.93	0.09	0.07	-0.66	0.71	0.34	0.72	0.38	0.33	0.61	-0.84	0.2	-0.66	0.57	-0.95		0.78	-0.9
Net Tangible Assets	0.76	0.78	-0.19	0.78	-0.05	0.13	-0.39	0.12	0.67	0.17	-0.08	-0.44	0.75	0.32	0.55	0.26	0.58	0.38	-0.88	-0.06	-0.44	0.84	-0.76	0.78		-0.79
Net Receivables	-0.48	-0.49	0.15	-0.47	0.19	-0.2	0.76	0.35	-0.74	0.02	-0.04	0.84	-0.68	-0.12	-0.42	-0.51	-0.43	-0.75	0.83	-0.18	0.84	-0.58	0.77	-0.9	-0.79

Click cells to compare fundamentals

Medibank Private Account Relationship Matchups

Medibank Private balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.7B	3.9B	4.6B	4.4B	4.7B	3.1B
Total Stockholder Equity	1.8B	1.9B	1.9B	2.1B	2.3B	1.5B
Other Liab	117.7M	97.1M	120.5M	177.3M	203.9M	174.3M
Retained Earnings	1.7B	1.8B	1.8B	2.0B	2.1B	1.4B
Accounts Payable	230.2M	239.9M	241.4M	215.7M	163.8M	171.5M
Cash	871.4M	671.7M	596.7M	420.6M	691M	573.5M
Other Assets	2.3B	2.7B	3.5B	3.5B	(6.9B)	(6.6B)
Short Term Investments	2.0B	2.3B	2.9B	2.9B	236.9M	225.1M
Total Liab	1.9B	2.0B	2.6B	2.3B	2.4B	2.5B
Intangible Assets	363.7M	345.3M	332.3M	328.1M	143.3M	218.0M
Property Plant Equipment	112.2M	101.7M	88.4M	70.5M	81.1M	72.4M
Other Current Liab	(315.8M)	(268M)	(388.6M)	1.3B	12.1M	12.7M
Total Current Liabilities	1.1B	1.0B	1.6B	1.3B	364.2M	518.5M
Net Debt	(762.2M)	(578.3M)	(519.8M)	(365.3M)	(472.7M)	(496.3M)
Non Current Assets Total	674.5M	718.1M	876.2M	755.5M	6.9B	7.2B
Non Currrent Assets Other	(2.1B)	(2.4B)	(2.9B)	(3.0B)	(3.5B)	(3.4B)
Cash And Short Term Investments	871.4M	671.7M	596.7M	420.6M	927.9M	702.2M
Liabilities And Stockholders Equity	3.7B	3.9B	4.6B	4.4B	4.7B	3.9B
Other Current Assets	3.1B	3.2B	3.7B	3.4B	3.8B	2.7B
Other Stockholder Equity	(1.8B)	(1.9B)	(1.9B)	(2.1B)	(1.9B)	(1.8B)
Total Current Assets	3.1B	3.2B	3.7B	3.6B	4.7B	5.0B
Accumulated Other Comprehensive Income	22.4M	22.3M	25.7M	27.9M	152.3M	159.9M
Net Tangible Assets	1.4B	1.6B	1.6B	1.8B	2.0B	1.6B
Net Receivables	207.1M	215.9M	225.4M	248.1M	39.5M	37.5M
Short Term Debt	27.9M	28.1M	30.2M	30.9M	66.6M	63.3M
Non Current Liabilities Total	880.1M	978.3M	1.0B	997.2M	2.4B	2.5B
Inventory	(1.1B)	(887.6M)	(822.1M)	(668.7M)	(967.4M)	(1.0B)
Long Term Investments	298.4M	343.8M	338.3M	392.1M	295.6M	334.5M
Long Term Debt Total	81.3M	65.3M	46.7M	24.4M	28.1M	34.2M
Net Invested Capital	1.8B	1.9B	1.9B	2.1B	2.3B	2.1B
Cash And Equivalents	871.4M	671.7M	596.7M	420.6M	378.5M	489.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Medibank Stock Analysis

When running Medibank Private's price analysis, check to measure Medibank Private's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medibank Private is operating at the current time. Most of Medibank Private's value examination focuses on studying past and present price action to predict the probability of Medibank Private's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medibank Private's price. Additionally, you may evaluate how the addition of Medibank Private to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC